News Focus
News Focus
icon url

MahinAgency

11/29/24 11:51 AM

#110 RE: moondogaz #92

NASDAQ: $CVKD BIG OPPORTUNITY

2025 Projected Revenue: $6.3 million, driven by potential initial commercialization of tecarfarin.

2026 Projected Revenue: $16.8 million, reflecting expected market adoption and growth?
Bullish
Bullish